SIMCERE PHARMAC. GRP LTD (S2P) — Capital Reinvestment Ratio
SIMCERE PHARMAC. GRP LTD (S2P) has a Capital Reinvestment Ratio of 0.43x as of December 2025, meaning it reinvests 0% of its operating cash flow (€2.01 Billion) in capital expenditures (€862.20 Million). See SIMCERE PHARMAC. GRP LTD balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SIMCERE PHARMAC. GRP LTD Capital Reinvestment Ratio (2022–2025)
This chart tracks SIMCERE PHARMAC. GRP LTD's Capital Reinvestment Ratio across 4 annual periods. Check SIMCERE PHARMAC. GRP LTD cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for SIMCERE PHARMAC. GRP LTD (2022–2025)
Year-by-year Capital Reinvestment Ratio for SIMCERE PHARMAC. GRP LTD from 2022 to 2025. For live market cap and broader valuation context, see SIMCERE PHARMAC. GRP LTD (S2P) total market value.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.43x | €2.01 Billion | €862.20 Million | ▼ -21.9% |
| 2024 | 0.55x | €1.39 Billion | €762.57 Million | ▼ -91.5% |
| 2023 | 6.49x | €151.05 Million | €979.86 Million | ▲ +1195.6% |
| 2022 | 0.50x | €1.35 Billion | €678.00 Million | — |